pharma · Weight management · Short Bowel Syndrome
Zealand Pharma
Zealand Pharma A/S
Zealand Pharma A/S is a pharma organization headquartered in EU. Primary therapeutic focus areas include Weight management, Short Bowel Syndrome, Children with congenital hyperinsulinism, Critically Ill, Mechanically Ven
Sydmarken 11, Søborg (Copenhagen), 2860, DK HQ
1998 Founded
596 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Sydmarken 11, Søborg (Copenhagen), 2860, DK
- Founded
- 1998
- Employees
- 596
- Programs
- 18
- Drugs
- 20
- Patents
- 0
TARGET protocol EN 1.5 kcal/mL
Phase 3 · other · Critical Illness
TARGET protocol EN 1.5 kcal/mL for Critical Illness is a Phase 3 program (other) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).
Internal code ANZIC-RC/MC001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zealand Pharma A/S
- Phase
- Phase 3
- Modality
- other
- Indication
- Critical Illness
- Status
- completed
- Trials
- 1